Mov Disord Vol 31, Suppl 2 Archives - Page 196 of 207 - MDS Abstracts

2016 International Congress
Eight weeks of home-based balance training not as effective as therapist-based during dual tasks
E.M. Atterbury, K.E. Welman (Stellenbosch, South Africa)
Objective: To assess the effect of balance training on dual-tasking gait, and to investigate if a home-based programme is comparable to a therapist-supervised programme. Background:…
2016 International Congress
Effects of safinamide in patients with Parkinson’s disease measured by Parkinson’s KinetiGraphTM
I. Suttrup, V. Zentsch, J. Schroeder, T. Warnecke (Muenster, Germany)
Objective: To objectively evaluate the effects of Safinamide in patients with Parkinson's (PD) by using the Parkinson's KinetiGraphTM (PKG), a newly developed tool for graphically…
2016 International Congress
New therapeutic algorithm for abnormal posture in Parkinson’s disease and related disorders
Y. Mukai, Y. Furusawa, Y. Aoshima, H. Todo, Y. Hama, C. Matsumoto, N. Wakasugi, Y. Mizuno, T. Kawazoe, Y. Saitoh, T. Sakamoto, M. Murata (Tokyo, Japan)
Objective: To establish the simple therapeutic algorithm for abnormal posture in Parkinson's disease (PD) or related disorders. Background: Camptocormia or dropped head are sometimes accompanied…
2016 International Congress
Creatine for patients with Parkinson’s disease: A meta-analysis
A. Attia, H. Ahmed, M. Morsi, K. Awad, M. Elnenny, E. Ghanem, A. Negida (Cairo, Egypt)
Objective: The aim of this systematic review and meta-analysis is to synthesize evidence from published randomized controlled trials (RCTs) about the efficacy of creatine for…
2016 International Congress
Upper limb motor tests are related to clinical ratings of motor function in advanced Parkinson’s disease
M. Memedi, S. Aghanavesi, D. Nyholm, H. Askmark, S.M. Aquilonius, R. Constantinescu, F. Bergquist, A. Medvedev, A. Ericsson, F. Ohlsson, S. Lycke, J. Spira, M. Senek, J. Westin (Falun, Sweden)
Objective: The aim of this study was to investigate whether upper limb motor tests are related to clinical ratings of motor function in Parkinson's disease…
2016 International Congress
Objective measurement in clinical care of patients with Parkinson’s disease
M. Horne, K. Kotschet, M. Braybrook (Parkville, Australia)
Objective: To establish whether using the Parkinson's KinetiGraph™ which provides objective measures in activities of daily living, helps identify unknown poorly controlled patients with Parkinson's…
2016 International Congress
The NIC-PD-study –Baseline data of a randomized, placebo-controlled, double-blind, multi-centre trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson’s disease in Germany and the USA
W.H. Oertel, C. Brittinger, C. Kamp, K. Balthasar, K. Articus, M. Brinkman, C. Venuto, H. Mueller, M.M. Unger, K.M. Eggert, D. Vadasz, K. Kieburtz, J. Boyd (Marburg, Germany)
Objective: The primary endpoint of clinical progression is measured by change in the total UPDRS score between baseline and 1) after 52 weeks of study…
2016 International Congress
Motor phenotype classification in moderate to advanced PD: Data from the BioFIND study
L. Luo, H.F. Andrews, J.G. Goldman, R.N. Alcalay, T. Xie, P. Tuite, C. Henchcliffe, P. Hogarth, A. Amara, S. Frank, A. Rudolph, C. Casaceli, K. Gwinn, M. Sutherland, C. Kopil, L. Vincent, M. Frasier, U.J. Kang (New York, NY, USA)
Objective: To evaluate the validity of motor phenotype classification in response to dopaminergic agents in moderate to advanced Parkinson's disease (PD) patients enrolled in the…
2016 International Congress
Whole body vibration therapy with exercise enhances motor function and improves quality of life in Parkinson’s disease
O.K. Gruder, D.Y. Edmonston, G.Q. Barr, C.G. Maitland (Tallahassee, FL, USA)
Objective: To evaluate the short term effects of whole body vibration and exercise in patients with Parkinson's disease on overall quality of life, gait, tremor,…
2016 International Congress
Critical path for Parkinson’s, I: Data sharing and regulatory science in catalyzing innovation for Parkinson’s disease
K. Romero, D. Burn, M. Hu, A. Yarnell, C. Williams Gray, K. Marek, D. Grosset, M. Sutherland, M. Isaac, A. Bhattaram, V. Sinha, M.F. Gordon, P. Muglia, L. Slicker, W. Hirst, M. Facheris, J. Posener, M. Bani, B. Corrigan, R. Schindler, K. Tsai, T. Nicholas, J. Cedarbaum, J. Gallagher, S. Ford, E. Avilex, V. Kern, S. Arneric, D. Stephenson, A. Roach (Tucson, AZ, USA)
Objective: This presentation highlights a new precompetitive consortium based strategy for the successful development of regulatory-endorsed biomarkers and quantitative drug development platforms targeted at the…